外泌体miRNA与骨质疏松:中医药靶向治疗机制的前沿探索及研究进展
Exosomal miRNA and Osteoporosis: Frontier Exploration and Research Progress of Targeted Treatment Mechanism of Traditional Chinese Medicine
DOI: 10.12677/tcm.2024.1310374, PDF,   
作者: 杨 浩, 巫红利, 黎嘉濠, 唐 锐:成都中医药大学附属医院临床医学院,中医骨伤科,四川 成都;张 弛:成都中医药大学养生康复学院,中医养生学教研室,四川 成都
关键词: 骨质疏松症外泌体miRNA中医药信号通路Osteoporosis Exosomes miRNA Traditional Chinese Medicine Signal Pathway
摘要: 骨质疏松症(OP)在绝经后女性和老年男性中较为常见,是全球范围内极为普遍的一种慢性疾病。其主要特征是骨量呈下降趋势、骨骼的脆性不断提高以及骨微结构遭到破坏。外泌体包含了蛋白质、脂质、核酸等多种生物活性物质,能够在细胞间传递信息、调节生理功能,并在多种生理和病理过程中发挥重要作用。在其中,作为功能性组成部分的微小核糖核酸(miRNA)可通过对骨形成与骨吸收过程进行调控,进而参与骨质疏松症的发生和发展进程。虽然在中医典籍中没有明确关于骨质疏松症的记载,但是如今越来越多的人运用中医药来干预骨质疏松的进展。中医药具有副作用较小的优点,并且相关的体内外实验发现,中医药是通过调节外泌体miRNA来发挥作用的。本文阐述外泌体miRNA与骨质疏松骨组织更新和修复中的关系,以及总结中药如何通过外泌体miRNA对OP发挥作用。
Abstract: Osteoporosis (OP) is relatively common in postmenopausal women and elderly men and is an extremely common chronic disease worldwide. Its main characteristics are a downward trend in bone mass, increasing brittleness of bones, and destruction of bone microstructure. Exosomes contain various bioactive substances, such as proteins, lipids, and nucleic acids. They can transmit information between cells, regulate physiological functions, and play an important role in various physiological and pathological processes. Among them, microRNAs (miRNAs), as functional components, can regulate the processes of bone formation and bone resorption and thus participate in the occurrence and development of osteoporosis. Although there is no clear record of osteoporosis in traditional Chinese medicine classics, nowadays more and more people use traditional Chinese medicine to intervene in the progress of osteoporosis. Traditional Chinese medicine has the advantage of relatively small side effects. And relevant in vitro and in vivo experiments have found that traditional Chinese medicine exerts its effects by regulating exosomal miRNAs. This article elaborates on the relationship between exosomal miRNAs and the renewal and repair of osteoporotic bone tissue, and summarizes how traditional Chinese medicine exerts its effects on OP through exosomal miRNAs.
文章引用:杨浩, 巫红利, 黎嘉濠, 唐锐, 张弛. 外泌体miRNA与骨质疏松:中医药靶向治疗机制的前沿探索及研究进展[J]. 中医学, 2024, 13(10): 2524-2531. https://doi.org/10.12677/tcm.2024.1310374

参考文献

[1] 段克友, 官建中. 外泌体在骨质疏松症治疗中的研究进展[J]. 中国修复重建外科杂志, 2021, 35(12): 1642-1649.
[2] Gielen, E., Dupont, J., Dejaeger, M. and Laurent, M.R. (2023) Sarcopenia, Osteoporosis and Frailty. Metabolism, 145, Article 155638. [Google Scholar] [CrossRef] [PubMed]
[3] 赵宗权, 吴贻红, 汤振源, 等. 老年骨质疏松症流行病学调查及预防措施研究[J]. 中国骨质疏松杂志, 2019, 25(7): 994-997.
[4] Kanis, J.A., Cooper, C., Rizzoli, R. and Reginster, J.-Y. (2019) Executive Summary of the European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women. Calcified Tissue International, 104, 235-238. [Google Scholar] [CrossRef] [PubMed]
[5] 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J]. 中华骨质疏松和骨矿盐疾病杂志, 2019, 12(4): 317-318.
[6] Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., et al. (2013) Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. Archives of Osteoporosis, 8, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
[7] Cervellati, C., Bonaccorsi, G., Piva, I. and Greco, P. (2018) Oxidative Stress as a Possible Pathogenic Cofactor of Post-Menopausal Osteoporosis: Existing Evidence in Support of the Axis Oestrogen Deficiency-Redox Imbalance-Bone Loss. Indian Journal of Medical Research, 147, Article 341. [Google Scholar] [CrossRef] [PubMed]
[8] Krylova, S.V. and Feng, D. (2023) The Machinery of Exosomes: Biogenesis, Release, and Uptake. International Journal of Molecular Sciences, 24, Article 1337. [Google Scholar] [CrossRef] [PubMed]
[9] Yu, X., Odenthal, M. and Fries, J. (2016) Exosomes as Mirna Carriers: Formation-Function-Future. International Journal of Molecular Sciences, 17, Article 2028. [Google Scholar] [CrossRef] [PubMed]
[10] Yang, Y., Yujiao, W., Fang, W., Linhui, Y., Ziqi, G., Zhichen, W., et al. (2020) The Roles of Mirna, Lncrna and Circrna in the Development of Osteoporosis. Biological Research, 53, Article No. 40. [Google Scholar] [CrossRef] [PubMed]
[11] Behera, J., Ison, J., Tyagi, A., Mbalaviele, G. and Tyagi, N. (2022) Mechanisms of Autophagy and Mitophagy in Skeletal Development, Diseases and Therapeutics. Life Sciences, 301, Article 120595. [Google Scholar] [CrossRef] [PubMed]
[12] Bottani, M., Banfi, G. and Lombardi, G. (2019) Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis. Frontiers in Genetics, 10, Article 1044. [Google Scholar] [CrossRef] [PubMed]
[13] Armas, L.A.G. and Recker, R.R. (2012) Pathophysiology of Osteoporosis. Endocrinology and Metabolism Clinics of North America, 41, 475-486. [Google Scholar] [CrossRef] [PubMed]
[14] Tu, C., He, J., Chen, R. and Li, Z. (2020) The Emerging Role of Exosomal Non-Coding RNAs in Musculoskeletal Diseases. Current Pharmaceutical Design, 25, 4523-4535. [Google Scholar] [CrossRef] [PubMed]
[15] Zhu, Y., Li, Z., Zhang, Y., Lan, F., He, J. and Wu, Y. (2020) The Essential Role of Osteoclast-Derived Exosomes in Magnetic Nanoparticle-Infiltrated Hydroxyapatite Scaffold Modulated Osteoblast Proliferation in an Osteoporosis Model. Nanoscale, 12, 8720-8726. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, Y., Kuek, V., Liu, Y., Tickner, J., Yuan, Y., Chen, L., et al. (2018) MiR-214 Is an Important Regulator of the Musculoskeletal Metabolism and Disease. Journal of Cellular Physiology, 234, 231-245. [Google Scholar] [CrossRef] [PubMed]
[17] Li, D., Liu, J., Guo, B., Liang, C., Dang, L., Lu, C., et al. (2016) Osteoclast-Derived Exosomal miR-214-3p Inhibits Osteoblastic Bone Formation. Nature Communications, 7, Article No. 10872. [Google Scholar] [CrossRef] [PubMed]
[18] Zhu, S., Yao, F., Qiu, H., Zhang, G., Xu, H. and Xu, J. (2017) Coupling Factors and Exosomal Packaging Micrornas Involved in the Regulation of Bone Remodelling. Biological Reviews, 93, 469-480. [Google Scholar] [CrossRef] [PubMed]
[19] Chen, M., Li, Y., Lv, H., Yin, P., Zhang, L. and Tang, P. (2020) Quantitative Proteomics and Reverse Engineer Analysis Identified Plasma Exosome Derived Protein Markers Related to Osteoporosis. Journal of Proteomics, 228, Article 103940. [Google Scholar] [CrossRef] [PubMed]
[20] Xu, R., Shen, X., Si, Y., Fu, Y., Zhu, W., Xiao, T., et al. (2018) MicroRNA-31a-5p from Aging BMSCs Links Bone Formation and Resorption in the Aged Bone Marrow Microenvironment. Aging Cell, 17, e12794. [Google Scholar] [CrossRef] [PubMed]
[21] Lu, Q., Qin, H., Tan, H., Wei, C., Yang, X., He, J., et al. (2021) Senescence Osteoblast-Derived Exosome-Mediated Mir-139-5p Regulates Endothelial Cell Functions. BioMed Research International, 2021, 1-12. [Google Scholar] [CrossRef] [PubMed]
[22] 何姣姣, 陈以发, 陈玉林, 等. 绝经后骨质疏松的骨免疫学机制[J]. 中国骨质疏松杂志, 2023, 29(7): 1032-1036.
[23] 瞿霖, 赵梦幻, 王冬玉, 等. 雌激素受体α在绝经后骨质疏松中的研究进展及作用机制[J]. 中国骨质疏松杂志, 2024, 30(7): 1021-1027.
[24] 顾亚, 李毅, 陈铭, 等. 不同细胞来源外泌体在骨质疏松小鼠体内的骨靶向性比较[J]. 解放军医学院学报, 2021, 42(3): 310-314.
[25] Luo, Z., Li, F., Liu, Y., Rao, S., Yin, H., Huang, J., et al. (2019) Aptamer-Functionalized Exosomes from Bone Marrow Stromal Cells Target Bone to Promote Bone Regeneration. Nanoscale, 11, 20884-20892. [Google Scholar] [CrossRef] [PubMed]
[26] 叶庆元, 邱新毓, 田荣, 等. 供体MSCs来源的外泌体转运miR-26a恢复宿主MSCs功能并缓解骨质疏松[J]. 实用口腔医学杂志, 2017, 33(5): 575-579.
[27] Chen, X., Wang, Z., Duan, N., Zhu, G., Schwarz, E.M. and Xie, C. (2017) Osteoblast-Osteoclast Interactions. Connective Tissue Research, 59, 99-107. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, J., Fu, W., He, M., Xie, W., Lv, Q., Wan, G., et al. (2011) MiRNA-20a Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells by Co-Regulating BMP Signaling. RNA Biology, 8, 829-838. [Google Scholar] [CrossRef] [PubMed]
[29] Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., et al. (2019) The Regulation of Bone Metabolism and Disorders by Wnt Signaling. International Journal of Molecular Sciences, 20, Article 5525. [Google Scholar] [CrossRef] [PubMed]
[30] Vimalraj, S., Partridge, N.C. and Selvamurugan, N. (2014) A Positive Role of MicroRNA-15b on Regulation of Osteoblast Differentiation. Journal of Cellular Physiology, 229, 1236-1244. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, F., Cao, K., Du, G., Zhang, Q. and Yin, Z. (2019) miR-29a Promotes Osteoblast Proliferation by Downregulating DKK-1 Expression and Activating Wnt/β-Catenin Signaling Pathway. Advances in Clinical and Experimental Medicine, 28, 1293-1300. [Google Scholar] [CrossRef] [PubMed]
[32] Elson, A., Anuj, A., Barnea-Zohar, M. and Reuven, N. (2022) The Origins and Formation of Bone-Resorbing Osteoclasts. Bone, 164, Article 116538. [Google Scholar] [CrossRef] [PubMed]
[33] Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., et al. (2005) DC-STAMP Is Essential for Cell-Cell Fusion in Osteoclasts and Foreign Body Giant Cells. The Journal of Experimental Medicine, 202, 345-351. [Google Scholar] [CrossRef] [PubMed]
[34] Dou, C., Zhang, C., Kang, F., Yang, X., Jiang, H., Bai, Y., et al. (2014) miR-7b Directly Targets DC-STAMP Causing Suppression of Nfatc1 and C-Fos Signaling during Osteoclast Fusion and Differentiation. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1839, 1084-1096. [Google Scholar] [CrossRef] [PubMed]
[35] Lee, Y., Kim, H.J., Park, C.K., Kim, Y., Lee, H., Kim, J., et al. (2013) MicroRNA-124 Regulates Osteoclast Differentiation. Bone, 56, 383-389. [Google Scholar] [CrossRef] [PubMed]
[36] Tang, L., Yin, Y., Liu, J., Li, Z. and Lu, X. (2017) miR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes via Targeting Rab27a. Cellular Physiology and Biochemistry, 43, 1663-1672. [Google Scholar] [CrossRef] [PubMed]
[37] Minamizaki, T., Nakao, Y., Irie, Y., Ahmed, F., Itoh, S., Sarmin, N., et al. (2020) The Matrix Vesicle Cargo miR-125b Accumulates in the Bone Matrix, Inhibiting Bone Resorption in Mice. Communications Biology, 3, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[38] 史晓林, 刘康. 老年性骨质疏松症中西医结合诊疗指南[J]. 中国骨质疏松杂志, 2024, 30(7): 937-946.
[39] 葛继荣, 王和鸣, 郑洪新, 等. 中医药防治原发性骨质疏松症专家共识(2020) [J]. 中国骨质疏松杂志, 2020, 26(12): 1717-1725.
[40] 叶佰盛, 李威, 黄振, 等. 从《内经》“生病起于过用”探讨原发性骨质疏松症因机证治[J]. 中国骨质疏松杂志, 2024, 30(2): 246-249.
[41] 张文明. miR-141调控OP小鼠BMSCs成骨分化机制及健骨颗粒干预作用研究[D]: [博士学位论文]. 福州: 福建中医药大学, 2016.
[42] 汪青. 二仙汤治疗肾阳虚型绝经后骨质疏松症的临床疗效评价及基于网络药理学的机制研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2021.
[43] 潘欣, 曾思良, 梁兴伦, 等. MicroRNA-195-5p调节Bmpr1α表达对骨髓间充质干细胞成脂分化的影响[J]. 同济大学学报(医学版), 2017, 38(3): 1-7+13.
[44] 陈哲. 糖尿病骨质疏松中医证型及滋肾降糖丸干预作用研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2018.
[45] 张昊, 余翔, 任辉, 等. 左归丸调控miR34a对BMSCs成骨分化能力的影响[J]. 辽宁中医杂志, 2018, 45(6): 1300-1304.
[46] He, C., Wang, Z. and Shi, J. (2020) Pharmacological Effects of Icariin. Advances in Pharmacology, 87, 179-203. [Google Scholar] [CrossRef] [PubMed]
[47] 袁雯霞, 赵杨敏, 干云霄, 等. 淫羊藿苷对缺糖缺氧条件下间充质干细胞活性及旁分泌功能的影响[J]. 浙江医学教育, 2020, 19(2): 41-44.
[48] 杨傲飞. 基于肾主骨生髓理论研究淫羊藿苷调控外泌体内miR-122-5p对BMSCs成骨、迁移的作用及机制[D]: [博士学位论文]. 武汉: 湖北中医药大学, 2020.
[49] 孙海涛. LncRNA TIM3/miR-214-5p/Samd4轴在绝经后骨质疏松症中的分子机制及淫羊藿苷的干预效应[D]: [博士学位论文]. 南京: 南京中医药大学, 2021.
[50] 徐月新. miR-664-3p通过靶向调节Smad4和Osterix的表达而促进骨质疏松的发生[D]: [硕士学位论文]. 南京: 南京中医药大学, 2015.
[51] 郭招娣. 异补骨脂素干预后BMSCs源性外泌体调控MC3T3-E1成骨分化的研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2019.
[52] 张莹莹. 葛根素对成骨细胞miRNA-204的调控及其与Runx2基因表达的关系[D]: [硕士学位论文]. 南京: 南京中医药大学, 2016.
[53] Huang, M., Zhuang, Y., Ning, X., Zhang, H., Shen, Z. and Shang, X. (2020) Artesunate Inhibits Osteoclastogenesis through the miR-503/Rank Axis. Bioscience Reports, 40, BSR20194387. [Google Scholar] [CrossRef] [PubMed]
[54] Zeng, H., Dong, L., Xu, C., Zhao, X. and Wu, L. (2020) Artesunate Promotes Osteoblast Differentiation through miR-34a/DKK1 Axis. Acta Histochemica, 122, Article 151601. [Google Scholar] [CrossRef] [PubMed]
[55] Zhang, Y., Liu, M., He, Y., Deng, N., Chen, Y., Huang, J., et al. (2020) Protective Effect of Resveratrol on Estrogen Deficiency-Induced Osteoporosis Though Attenuating NADPH Oxidase 4/nuclear Factor Kappa B Pathway by Increasing miR-92b-3p Expression. International Journal of Immunopathology and Pharmacology, 34, Article 205873842094176. [Google Scholar] [CrossRef] [PubMed]